• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对一种简单、高产的生产完全折叠和功能正常的重组人 CCL5 的方法有了新的认识。

New insight into a simple high-yielding method for the production of fully folded and functional recombinant human CCL5.

机构信息

Hull York Medical School, University of York, York, YO10 5DD, UK.

Department of Chemistry, University of York, York, YO10 5DD, UK.

出版信息

Sci Rep. 2024 Oct 15;14(1):24188. doi: 10.1038/s41598-024-75327-y.

DOI:10.1038/s41598-024-75327-y
PMID:39406925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11480376/
Abstract

Chemokines are proteins important for a range of biological processes from cell-directed migration (chemotaxis) to cell activation and differentiation. Chemokine C-C ligand 5 (CCL5) is an important pro-inflammatory chemokine attracting immune cells towards inflammatory sites through interaction with its receptors CCR1/3/5. Recombinant production of large quantities of CCL5 in Escherichia coli is challenging due to formation of inclusion bodies which necessitates refolding, often leading to low recovery of biologically active protein. To combat this, we have developed a method for CCL5 production that utilises the purification of SUMO tagged CCL5 from E. coli SHuffle cells avoiding the need to reform disulfide bonds through inclusion body purification and yields high quantities of CCL5 (~ 25 mg/L). We demonstrated that the CCL5 produced was fully functional by assessing well-established cellular changes triggered by CCL5 binding to CCR5, including receptor phosphorylation and internalisation, intracellular signalling leading to calcium flux, as well as cell migration. Overall, we demonstrate that the use of solubility tags, SHuffle cells and low pH dialysis constitutes an approach that increases purification yields of active CCL5 with low endotoxin contamination for biological studies.

摘要

趋化因子是一类在细胞定向迁移(趋化作用)到细胞激活和分化等多种生物学过程中发挥重要作用的蛋白质。趋化因子 C-C 配体 5(CCL5)是一种重要的促炎趋化因子,通过与其受体 CCR1/3/5 的相互作用,将免疫细胞吸引到炎症部位。由于形成包涵体,大肠杆菌中大量重组生产 CCL5 具有挑战性,这需要进行重折叠,通常导致具有生物活性的蛋白质回收率低。为了解决这个问题,我们开发了一种利用 SUMO 标记的 CCL5 从大肠杆菌 SHuffle 细胞中进行纯化的方法,避免了通过包涵体纯化来重新形成二硫键的需要,并产生了大量的 CCL5(~25mg/L)。我们通过评估 CCL5 与 CCR5 结合引发的成熟细胞的变化,包括受体磷酸化和内化、细胞内信号转导导致钙流以及细胞迁移,证明了所产生的 CCL5 是完全有功能的。总的来说,我们证明了使用可溶性标签、SHuffle 细胞和低 pH 透析的方法可以提高活性 CCL5 的纯化产量,同时降低内毒素污染,适用于生物学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/97e2d612de8e/41598_2024_75327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/4797c4b0617a/41598_2024_75327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/257417350ba8/41598_2024_75327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/1a94ee73d0f0/41598_2024_75327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/5af2dabc446d/41598_2024_75327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/97e2d612de8e/41598_2024_75327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/4797c4b0617a/41598_2024_75327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/257417350ba8/41598_2024_75327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/1a94ee73d0f0/41598_2024_75327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/5af2dabc446d/41598_2024_75327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88aa/11480376/97e2d612de8e/41598_2024_75327_Fig5_HTML.jpg

相似文献

1
New insight into a simple high-yielding method for the production of fully folded and functional recombinant human CCL5.对一种简单、高产的生产完全折叠和功能正常的重组人 CCL5 的方法有了新的认识。
Sci Rep. 2024 Oct 15;14(1):24188. doi: 10.1038/s41598-024-75327-y.
2
C-terminal engineering of CXCL12 and CCL5 chemokines: functional characterization by electrophysiological recordings.CXCL12 和 CCL5 趋化因子的 C 末端工程化:通过电生理记录进行功能表征。
PLoS One. 2014 Jan 31;9(1):e87394. doi: 10.1371/journal.pone.0087394. eCollection 2014.
3
Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.纤维环细胞表达并利用C-C趋化因子受体5(CCR5)进行迁移。
Spine J. 2017 May;17(5):720-726. doi: 10.1016/j.spinee.2017.01.010. Epub 2017 Jan 17.
4
An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.CCR1介导的下游信号事件的流产型配体诱导激活以及CCR5表达的缺陷与人初始CD4 + T细胞对CCL3和CCL5的低反应性相关。
J Immunol. 2002 Jun 15;168(12):6263-72. doi: 10.4049/jimmunol.168.12.6263.
5
Genetic Polymorphism at Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1 and CCR5 Cells in Chronic Chagasic Cardiomyopathy.基因多态性与恰加斯心脏病的保护有关:CCR1 和 CCR5 细胞在慢性恰加斯心肌病中的拮抗参与。
Front Immunol. 2018 Apr 11;9:615. doi: 10.3389/fimmu.2018.00615. eCollection 2018.
6
Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.转移性 NOE 观察到的变价配位:CCR5 N 端片段中磺酸化酪氨酸残基与 CCL5 趋化因子的相互作用。
FEBS J. 2021 Mar;288(5):1648-1663. doi: 10.1111/febs.15503. Epub 2020 Sep 8.
7
On-column refolding of recombinant chemokines for NMR studies and biological assays.用于核磁共振研究和生物学测定的重组趋化因子柱上重折叠
Protein Expr Purif. 2007 Mar;52(1):202-9. doi: 10.1016/j.pep.2006.09.009. Epub 2006 Sep 24.
8
Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.CCL5-CCR5 轴在口腔扁平苔藓中的表达及生物学功能。
Exp Dermatol. 2019 Jul;28(7):816-821. doi: 10.1111/exd.13946. Epub 2019 May 15.
9
Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.趋化因子 C-C 基元受体 5 和 C-C 基元配体 5 在缺氧下促进癌细胞迁移。
Cancer Sci. 2012 May;103(5):904-12. doi: 10.1111/j.1349-7006.2012.02259.x. Epub 2012 Apr 12.
10
Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.β-arrestin 募集到 C-C 趋化因子受体 5:有效的 C-C 趋化因子配体 5 类似物揭示了对受体磷酸化的依赖性和同种型特异性募集偏向的差异。
Mol Pharmacol. 2020 Nov;98(5):599-611. doi: 10.1124/molpharm.120.000036. Epub 2020 Sep 17.

本文引用的文献

1
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.CXCL17 与糖胺聚糖有效结合,具有调节趋化因子信号的潜力。
Front Immunol. 2023 Oct 24;14:1254697. doi: 10.3389/fimmu.2023.1254697. eCollection 2023.
2
Expression and purification of recombinant human CCL5 and its biological characterization.表达和纯化重组人 CCL5 及其生物学特性。
Protein J. 2022 Apr;41(2):337-344. doi: 10.1007/s10930-022-10047-8. Epub 2022 May 7.
3
A highly efficient method for the production and purification of recombinant human CXCL8.
一种高效生产和纯化重组人 CXCL8 的方法。
PLoS One. 2021 Oct 15;16(10):e0258270. doi: 10.1371/journal.pone.0258270. eCollection 2021.
4
CCL5/CCR5 axis in human diseases and related treatments.人类疾病及相关治疗中的CCL5/CCR5轴
Genes Dis. 2022 Jan;9(1):12-27. doi: 10.1016/j.gendis.2021.08.004. Epub 2021 Aug 26.
5
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.CC 趋化因子受体 5 激动剂激活的结构基础。
Sci Adv. 2021 Jun 16;7(25). doi: 10.1126/sciadv.abg8685. Print 2021 Jun.
6
The CCL5/CCR5 Axis in Cancer Progression.癌症进展中的CCL5/CCR5轴
Cancers (Basel). 2020 Jul 2;12(7):1765. doi: 10.3390/cancers12071765.
7
Integrative Model to Coordinate the Oligomerization and Aggregation Mechanisms of CCL5.整合模型以协调 CCL5 的寡聚化和聚集机制。
J Mol Biol. 2020 Feb 14;432(4):1143-1157. doi: 10.1016/j.jmb.2019.12.049. Epub 2020 Jan 11.
8
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology.针对癌症的 CCR5 靶点及在免疫肿瘤学中的作用的最新进展
Cancer Res. 2019 Oct 1;79(19):4801-4807. doi: 10.1158/0008-5472.CAN-19-1167. Epub 2019 Jul 10.
9
CCR5 is a required signaling receptor for macrophage expression of inflammatory genes in response to viral double-stranded RNA.CCR5 是一个必需的信号受体,可促进巨噬细胞表达炎症基因以响应病毒双链 RNA。
Am J Physiol Regul Integr Comp Physiol. 2019 May 1;316(5):R525-R534. doi: 10.1152/ajpregu.00019.2019. Epub 2019 Feb 27.
10
CCR5: Established paradigms and new frontiers for a 'celebrity' chemokine receptor.CCR5:作为“明星”趋化因子受体的既定范例和新前沿
Cytokine. 2018 Sep;109:81-93. doi: 10.1016/j.cyto.2018.02.018.